For institutional investors in the UK

Daniel Lyons, PhD, CFA

Portfolio Manager | Research Analyst
Daniel Lyons, Ph.D., CFA | Janus Henderson Investors

Daniel Lyons is a Portfolio Manager and Research Analyst at Janus Henderson Investors responsible for co-managing the Biotechnology strategy since 2018. Daniel started consulting for Janus in 1997 and joined the Health Care Sector Research Team full time in 2000. As a research analyst, he focuses on the biotechnology and life science tools sectors.

Daniel received his bachelor of arts degree in biochemistry and chemistry from Rice University, graduating magna cum laude. He also earned a PhD from Stanford University’s programme in immunology and conducted postdoctoral research with a Nobel Laureate at the University of Colorado. He holds the Chartered Financial Analyst designation and has 21 years of financial industry experience.

Articles Written

COVID variants: The impact on pandemic trajectory & biopharma stocks
February 2021
Investment Viewpoints Coronavirus Healthcare

COVID variants: The impact on pandemic trajectory & biopharma stocks

Making sense of the latest developments around COVID-19 variants and what investors should consider now.

Watch Now

COVID-19: Understanding the science & investment implications (Part 4)
May 2020
Investment Viewpoints Coronavirus Healthcare

COVID-19: Understanding the science & investment implications (Part 4)

A new video series from our health care team offers unique insight into the scientific and investment implications of the COVID-19 crisis.

Read More

Legal information | Privacy policy | Cookie policy | Security information

 

Cookies: The Janus Henderson Investors website uses cookies to remember your preferences and to help us to improve the site through the use of web analytics. By continuing without changing your cookie settings we will assume that you are happy to receive cookies for these two purposes. For full details on how to manage our cookies and how we use them, please see our cookie policy.

 

This website is intended solely for the use of institutional investors and consultants and is not for general public distribution. The value of an investment and the income from it can fall as well as rise and you may not get back the amount originally invested.

 

There is no assurance that the investment process will consistently lead to successful investing. Any risk management process discussed includes an effort to monitor and manage risk, which should not be confused with, and does not imply, low risk or the ability to control certain risk factors. The availability of our services and vehicles is subject to applicable laws, which may differ from one jurisdiction to another.

 

Issued in the UK by Janus Henderson Investors. Janus Henderson Investors is the name under which investment products and services are provided by Janus Capital International Limited (reg no. 3594615), Henderson Global Investors Limited (reg. no. 906355), Henderson Investment Funds Limited (reg. no. 2678531), Henderson Equity Partners Limited (reg. no.2606646), (each registered in England and Wales at 201 Bishopsgate, London EC2M 3AE and regulated by the Financial Conduct Authority) and Henderson Management S.A. (reg no. B22848 at 2 Rue de Bitbourg, L-1273, Luxembourg and regulated by the Commission de Surveillance du Secteur Financier).

 

We may record telephone calls for our mutual protection, to improve customer service and for regulatory record keeping purposes.

 

Janus Henderson, Perkins, Intech, VelocityShares, Knowledge Shared, Knowledge. Shared and Knowledge Labs are trademarks of Janus Henderson Group plc or one of its subsidiaries. © Janus Henderson Group plc.